Chronic Lymphocytic Leukemia Study of Duvelisib Treatment Fully Enrolled
News
Infinity Pharmaceuticals announced its has reached its target enrollment of 300 patients in DUO, a randomized Phase 3 clinical trial evaluating the safety and efficacy of duvelisib in comparison with the standard of treatment, ... Read more